Abstract

Reproductive technologies are increasingly used not just to detect the presence of fetal “abnormalities” but also to “correct” or eliminate them before birth. This is done with the aim to enable the birth of “healthy” and “normal” children who can contribute better to the nation’s productivity. Although these processes are common to most women, the situation is further aggravated for surrogates within developing country contexts, who already work in precarious conditions and occupy the lower end of the hierarchy within the surrogacy arrangement. Highlighting the Indian surrogacy context, I discuss and analyze some of these biopolitical challenges and complexities.